Does Medicare Cover Menest? Part D Costs Explained
Medicare Part D covers Menest and most HRT drugs, but tier and prior authorization affect cost. Generics run $10-30/month; brand HRT can exceed $150.
Medicare Part D covers Menest and most HRT drugs, but tier and prior authorization affect cost. Generics run $10-30/month; brand HRT can exceed $150.
Menopause brain fog is a real, measurable cognitive change driven by declining estrogen. Learn what the research says, which treatments work, and when to see a doctor.
Declining estrogen during menopause causes collagen loss, dryness, thinning hair, and increased shedding. Learn what the evidence says about topical, systemic, and lifestyle options that actually work.
A detailed comparison of online HRT clinics for women, covering monthly costs, insurance coverage, Medicare rules, and prior authorization steps. prepared by the HealthRX.com Editorial Team.
A comparison of estradiol patches and estradiol gels covering absorption, dosing, side effects, cost, and who benefits most from each form of transdermal HRT.
A breakdown of estradiol, progesterone, and testosterone dosing schedules for women on HRT, covering pellets, patches, oral micronized progesterone, and topical testosterone cream.
A detailed clinical comparison of hormone pellets vs estradiol patches for women's HRT, covering pharmacokinetics, safety data, cost, and how to choose between bioidentical, compounded, and FDA-approved options.
A guide to major perimenopause symptoms, from hot flashes and night sweats to vaginal dryness and insomnia, with an evidence-based look at treatment options and diagnostic guidance.
Compare cyclic versus daily oral progesterone with estrogen: dosing evidence, bleeding patterns, formulation differences and switching calendars.
Progesterone binds PR-A and PR-B receptors to alter gene transcription; micronized progesterone matches this action, unlike synthetic progestins like MPA.
A clinically grounded guide to testosterone therapy for women, covering benefits, dosing, safety data, and how it fits alongside estradiol patches, gels, sprays, and oral options.
A deep dive into the mechanism of testosterone in women, covering androgen receptors, aromatization, first-pass metabolism, estrogen receptor cross-talk, and what happens at menopause.
Formication is a menopause symptom causing crawling-insect sensations on skin due to falling estrogen. Learn causes and treatments that help, including HRT.
A deep look at whether applying estrogen cream or serum to the face triggers acne breakouts or darkens melasma patches, with dosing context, skin biology, and practical guidance.
Evidence-based strategies for losing weight during menopause, including diet, exercise, hormone therapy, and GLP-1 options.
A guide covering how long perimenopause, menopause, and postmenopause each last, what drives symptom duration, and when to consider hormone therapy.
A guide to preventing and treating vaginal dryness during menopause, covering estrogen therapy, non-hormonal options, lifestyle changes, and when to seek care.
The menopause transition reshapes your gut bacteria. Learn which evidence-based strategies, including diet, probiotics, and hormone therapy, can help restore gut microbiome health during menopause.
A complete clinical guide to menopause: what it is, the three stages, hallmark symptoms, how it's diagnosed, and evidence-based hormone therapy options prepared by the HealthRX.com Editorial Team.
Joint pain during menopause is caused by estrogen loss that drives cartilage breakdown, synovial inflammation, and tendon stiffness. Learn the mechanisms, evidence-based treatments, and when hormone therapy actually helps.
Randi Friedman shares why she is passionate about working at Alloy Women's Health, how the telehealth platform is changing menopause and HRT care, and what clinicians and patients can expect from personalized hormone therapy.
A breakdown of HRT and cardiovascular risk in 2026, covering the WHI reanalysis, timing hypothesis, oral vs. Transdermal estrogen, progestogen type, and who should avoid HRT.
A guide to compounded testosterone cream for women, covering doses, clinical evidence, comparisons with vaginal estradiol and DHEA, flibanserin, and bremelanotide, and how to get a prescription.
Surgical menopause causes hormone levels to drop within 24 hours, often with more severe symptoms and earlier heart and bone risks than natural menopause.
Painful sex after menopause is caused by estrogen loss that thins vaginal tissue, reduces lubrication, and triggers GSM. Local estrogen, systemic HRT, ospemifene, testosterone, and lifestyle changes can restore comfort and desire. Learn which treatment fits your situation.
A clinical guide to switching from AndroGel (testosterone gel 1% or 1.62%) to other testosterone formulations, or switching to AndroGel from injections, pellets, or patches. Includes dosing conversions, washout timing, and monitoring benchmarks.
A clinical comparison of Defy Medical alternatives across TRT, peptides, HRT, and longevity care. Includes cost data, prescribing scope, and use-case recommendations backed by primary sources.
A clinical comparison of oral estradiol and vaginal estradiol covering titration speed, systemic absorption, tolerability, and when to switch routes. prepared by the HealthRX.com Editorial Team.
A clinical deep-dive into the unresolved debates around menopause-related weight gain, including whether estrogen loss causes fat redistribution, the role of HRT, GLP-1 agents, and what current guidelines get wrong.
A guide covering the pharmacokinetic and pharmacodynamic interaction between tretinoin topical and progesterone HRT, including CYP pathways, monitoring, dosing, and patient counseling backed by primary literature.
A guide to oral estradiol's off-label use for mood symptoms, covering the evidence base, GRADE ratings, FDA-approved indications, and key risks to weigh before prescribing.
A physician-level review of oral micronized progesterone (Prometrium) pharmacokinetics, covering absorption variability, peanut-oil matrix effects, hepatic metabolism, active neurosteroid metabolites, and clinical dosing implications backed by PubMed-cited evidence.
A synthesis of real-user side-effect reports for testosterone cypionate, cross-referenced with clinical trial data from the T-Trials and FDA labeling. Covers injection-site reactions, hematologic changes, mood shifts, and sexual side effects.
What real patients experience when they stop vaginal estradiol, why regret spikes after discontinuation, and how to restart safely. Backed by clinical trials, FDA labeling, and physician guidance.
A complete clinical guide to grading, explaining, and managing gynecomastia caused by AndroGel testosterone gel, including the Simon, McKinney grading scale, aromatization mechanism, FAERS data, and step-by-step treatment protocols.
A severity grading rubric for dizziness caused by oral micronized progesterone, covering mechanism, dose relationships, management strategies, and when to escalate care.
A clinical deep-dive into the potentially permanent side effects of testosterone cypionate, including testicular atrophy, infertility, cardiovascular changes, and how to reduce long-term risk.
A guide to testosterone cypionate monitoring protocols for men aged 50 to 64, covering lab timing, cardiovascular risk, hematocrit, prostate surveillance, and dose adjustment thresholds.
A deep dive into testosterone cypionate absorption, distribution, metabolism, and excretion, with PK data, dosing implications, and clinical trial evidence.
A GRADE-graded review of testosterone enanthate clinical evidence for male hypogonadism: sexual function, bone density, body composition, cardiovascular risk, and mood, with primary-literature citations and dosing guidance.
Methimazole is preferred for most adults; PTU is used in early pregnancy and thyroid storm. Compares doses, agranulocytosis risk, and liver failure warning.
A clinical guide to managing vaginal estradiol (Vagifem, Imvexxy, Estring, compounded) dosing schedules during travel, timezone shifts, and disrupted routines, with primary-literature citations and pharmacokinetic data.
A clinical guide covering Prometrium dosing, safety, monitoring, and care-transition planning for geriatric patients aged 65 and older, including fall risk, cognitive considerations, and drug interactions.
A clinical guide for geriatric patients (65+) transitioning to adult care with testosterone cypionate therapy: dosing, monitoring, risks, and guidelines.
A guide to Armour Thyroid (natural desiccated thyroid) storage conditions, shelf life, stability data, and what degradation means for your TSH control.
A guide to switching between Armour Thyroid (natural desiccated thyroid) and levothyroxine, liothyronine, or combination therapy. Covers dose conversion ratios, titration timelines, lab monitoring, and clinical decision points.
A detailed clinical comparison of enclomiphene citrate and Jatenzo (oral testosterone undecanoate) for male hypogonadism, covering trial data, testosterone restoration, fertility impact, safety profiles, and how to choose between them.
A clinical comparison of testosterone cypionate and enclomiphene citrate for male hypogonadism, covering efficacy, fertility impact, and how to switch safely between them.
A detailed clinical comparison of testosterone cypionate (injectable) and Jatenzo (oral testosterone undecanoate) for men's TRT, covering efficacy, dosing, safety, and how to choose between them.
A clinical comparison of testosterone cypionate injections and Jatenzo oral testosterone undecanoate, including how to switch safely between them, efficacy data, and dosing guidance.
A clinical comparison of enclomiphene citrate and AndroGel (testosterone gel 1%) for male hypogonadism, covering when to switch, what failure looks like, and how to manage the transition safely.
A clinical deep-dive comparing enclomiphene citrate and Jatenzo (oral testosterone undecanoate), including whether combining them makes sense, the risks involved, and when to switch.
A head-to-head clinical comparison of enclomiphene citrate and Jatenzo (oral testosterone undecanoate) for men's TRT, covering pharmacology, trial data, real-world outcomes, safety, and which patients are best suited for each therapy.
A clinical comparison of enclomiphene citrate and testosterone enanthate for long-term testosterone restoration in men, covering trial data, fertility preservation, axis suppression, and how to choose between them.
A head-to-head clinical comparison of enclomiphene citrate and testosterone enanthate for male hypogonadism, covering trial data, real-world outcomes, fertility preservation, switching protocols, and dosing.
A clinical comparison of enclomiphene citrate and testosterone enanthate covering titration speed, tolerability, fertility preservation, and switching protocols for men on TRT.
A clinical comparison of enclomiphene citrate and testosterone enanthate for male hypogonadism, with evidence-based guidance on switching protocols when your current therapy stops working.
A clinical comparison of testosterone cypionate and enclomiphene citrate across special populations including men seeking fertility preservation, older adults, obese men, and those with secondary hypogonadism.
A clinical comparison of injectable testosterone cypionate and oral testosterone undecanoate (Jatenzo) for long-term TRT durability, including trial data, dosing, risks, and switching guidance.
A clinically grounded comparison of injectable testosterone cypionate and oral Jatenzo (testosterone undecanoate), covering pharmacokinetics, efficacy data, cardiovascular risks, cost, and how to decide between them.